[Treatment of spasticity after traumatic brain injury in children: the role of botulinum toxin therapy].

Traumatic brain injury (TBI) is one of the main reasons of death and disability in children and adolescents in Russia and abroad. Spasticity is a frequent outcome of the TBI that influences on the rehabilitation prognosis, degree of movement disorders and quality of life after trauma. Early spasticity correction and complex rehabilitation lead to the optimal recovery and prevent secondary complications. This review presents the current data about the prognostic role of the spasticity in children after TBI, methods of its correction and their scientific evidence. Limitations and challenges of per-oral antispastic agents are described especially for the patients with local spasticity. Attention is focused on the methods of treatment of local hypertonus, in particular botulinum toxin A (BTA) injections proved to be effective in adults with acquired brain injury. The article summarizes the results of international investigations, systematic reviews and consensus statements about the efficacy and safety of botulinum toxin treatment in children after the TBI. The authors describe an algorithm of the optimal patient selection and goal setting for BTA injections in children with acquired brain injury.

[1]  В. П. Зыков,et al.  Многоуровневые инъекции ботулинического токсина типа а (абоботулотоксина) при лечении спастических форм детского церебрального паралича: ретроспективное исследование опыта 8 российских центров , 2016 .

[2]  Mark W. Green,et al.  Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache , 2016, Neurology.

[3]  R. Ware,et al.  Safety of Botulinum Toxin Type A for Children With Nonambulatory Cerebral Palsy , 2015, Pediatrics.

[4]  Валиуллина Светлана Альбертовна,et al.  Prevalence of Traumatic Brain Injury in Children of Russian Federation: Epidemiology and Economic Aspects , 2015 .

[5]  N. Gray,et al.  Moderate-to-Severe Traumatic Brain Injury in Children: Complications and Rehabilitation Strategies. , 2015, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.

[6]  I. Novak,et al.  A systematic review of interventions for children with cerebral palsy: state of the evidence , 2013, Developmental medicine and child neurology.

[7]  Лейла Сеймуровна Намазова-баранова,et al.  КОНТРОЛЬ ТОЧНОСТИ ИНЪЕКЦИЙ БОТУЛИНИЧЕСКОГО ТОКСИНА ТИПА А ПРИ СПАСТИЧЕСКИХ ФОРМАХ ДЕТСКОГО ЦЕРЕБРАЛЬНОГО ПАРАЛИЧА: ВЫБОР МЕТОДИКИ , 2013 .

[8]  Y. Awaad,et al.  Spasticity in children , 2012 .

[9]  С. М. Карпов,et al.  Когнитивные нарушения в остром периоде черепно-мозговой травмы у детей , 2011 .

[10]  S. Berweck,et al.  Botulinum toxin assessment, intervention and follow‐up for paediatric upper limb hypertonicity: international consensus statement , 2010, European journal of neurology.

[11]  L. Morrison,et al.  Practice Parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review) , 2010, Neurology.

[12]  L. Albright,et al.  Development of the Hypertonia Assessment Tool (HAT) , 2009, Developmental medicine and child neurology.

[13]  M. Vidailhet,et al.  Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A , 2009, Developmental neurorehabilitation.

[14]  J. Gracies,et al.  Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[15]  I. Novak,et al.  Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy , 2007, Developmental medicine and child neurology.

[16]  H. Keenan,et al.  Epidemiology and Outcomes of Pediatric Traumatic Brain Injury , 2006, Developmental Neuroscience.

[17]  V. Anderson,et al.  Planning, problem-solving and organizational abilities in children following traumatic brain injury: Intervention techniques , 2006, Pediatric rehabilitation.

[18]  E. M. Goldstein.  Safety of High-Dose Botulinum Toxin Type A Therapy for the Treatment of Pediatric Spasticity , 2006, Journal of child neurology.

[19]  D. Stokic,et al.  Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury. , 2005, Archives of physical medicine and rehabilitation.

[20]  Rainer Koch,et al.  Reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in adult patients with severe brain injury: a comparison study , 2005, Clinical rehabilitation.

[21]  C. Boake,et al.  Efficacy of early use of intrathecal baclofen therapy for treating spastic hypertonia due to acquired brain injury , 2005, Brain injury.

[22]  G. Molenaers,et al.  Botulinum toxin type A in the treatment of children and adolescents with an acquired brain injury , 2005, Brain injury.

[23]  R. Wenzelburger,et al.  Recovery of the precision grip in children after traumatic brain injury. , 2004, Archives of physical medicine and rehabilitation.

[24]  N. W. Pedersen,et al.  [Botulinum toxin treatment of spastic cerebral palsy]. , 2004, Ugeskrift for laeger.

[25]  V. Forin,et al.  [Botulinum toxin type A in children: evaluation of indications with a review of the literature]. , 2003, Annales de readaptation et de medecine physique : revue scientifique de la Societe francaise de reeducation fonctionnelle de readaptation et de medecine physique.

[26]  V. Forin,et al.  Toxine botulinique type A chez l’enfant : évaluation des indications à partir d’une revue de la littérature , 2003 .

[27]  S. Haley,et al.  Lower extremity spasticity as an early marker of ambulatory recovery following traumatic brain injury , 2003, Child's Nervous System.

[28]  T. Theologis,et al.  Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double‐blind, placebo‐controlled, dose‐ranging study , 2002, Developmental medicine and child neurology.

[29]  I. Autti-Rämö,et al.  Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications , 2001, European journal of neurology.

[30]  J. Meythaler,et al.  Prospective assessment of tizanidine for spasticity due to acquired brain injury. , 2001, Archives of physical medicine and rehabilitation.

[31]  H. Graham.  Botulinum toxin A in cerebral palsy: functional outcomes. , 2000, The Journal of pediatrics.

[32]  P D Adelson,et al.  Topical Review: Head Injury in Children , 1998, Journal of child neurology.

[33]  G. Francisco,et al.  Pharmacologic management of spasticity in adults with brain injury , 1997 .

[34]  S. Wisniewski,et al.  Cerebrovascular response in infants and young children following severe traumatic brain injury: a preliminary report. , 1997, Pediatric neurosurgery.

[35]  B. L. Bauer,et al.  Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury , 1997, Journal of Neurology.

[36]  C. Boake,et al.  Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury , 1996, Neurology.

[37]  B. Bioulac,et al.  A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[38]  M. Hadley,et al.  Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury. , 1996, Archives of physical medicine and rehabilitation.

[39]  L. Jarho,et al.  Long-term outcome after severe brain injury in preschoolers is worse than expected. , 1996, Archives of pediatrics & adolescent medicine.

[40]  З Ф Дудченко.  Тема психического здоровья в трудах С. С. Корсакова , 2018 .

[41]  O. Mokienko,et al.  [The efficacy of botulinum toxin therapy in patients with upper limb spasticity due to traumatic brain injury]. , 2016, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[42]  S. N. Medvedeva,et al.  [The First Russian Consensus on the Multilevel Abobotulinumtoxin A Injections in Spastic Forms of Cerebral Palsy]. , 2016, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[43]  P. Bose,et al.  Traumatic Brain Injury (TBI)-Induced Spasticity: Neurobiology, Treatment, and Rehabilitation , 2015 .

[44]  L. Namazova-Baranova,et al.  Botulinum toxin A injection precision control at spastic forms of cerebral palsy : choosing methodology , 2015 .

[45]  Лейла Сеймуровна Намазова-баранова,et al.  Необходимость и возможность создания банков донорского грудного молока в России: результаты социологического опроса в рамках пилотного проекта банка донорского молока на базе ФГБНУ «Научный центр здоровья детей» , 2015 .

[46]  S. Mehta,et al.  Evidence-Based Review of Moderate to Severe Acquired Brain Injury , 2013 .

[47]  Гулин Александр Владимирович,et al.  Применение немедикаментозных методов в лечении детского церебрального паралича , 2012 .

[48]  K. Desloovere,et al.  The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy. , 2010, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[49]  M. Bodeker,et al.  Chapter 1 – Multiple Steps in the Blockade of Exocytosis by Botulinum Neurotoxins , 2009 .

[50]  D. Knol,et al.  Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy. , 2007, Pediatric neurology.

[51]  M. Hadley,et al.  Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience. , 1999, Archives of physical medicine and rehabilitation.

[52]  D M Simpson,et al.  Traditional pharmacological treatments for spasticity part II: General and regional treatments , 1997, Muscle & nerve. Supplement.

[53]  A. B. Scott,et al.  Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. , 1980, Journal of pediatric ophthalmology and strabismus.